Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Analysis of HLA-DQB1*0602 in Multiple Sclerosis Patients in Khuzestan Province, Iran.
Targeted mutations in Val101 and Arg27 interferon beta protein increase its transcriptional and translational activities.
Tryptophan Metabolites and Their Impact on Multiple Sclerosis Progression.
Degenerative Cervical Myelopathy: A Spectrum of Related Disorders Affecting the Aging Spine.
Natural history of multiple sclerosis from the Indian perspective: Experience from a tertiary care hospital.
Acquired Demyelinating and Other Autoimmune Disorders of the Central Nervous System in Children.
Combining clinical and magnetic resonance imaging markers enhances prediction of 12-year disability in multiple sclerosis.
Quantitative evaluation of cerebral white matter in patients with multiple sclerosis using multicomponent T2 mapping.
Peroxisome proliferator-activated receptor-γ cofactors in neurodegeneration.
Assessment of prevalence and pathological response to orthostatic provocation in patients with multiple sclerosis.
Differential Regulation of CD4+ T Cell Adhesion to Cerebral Microvascular Endothelium by the β-Chemokines CCL2 and CCL3.
Natalizumab treatment for multiple sclerosis: Middle East and North Africa regional recommendations for patient selection and monitoring.
Widespread Pressure Pain Hypersensitivity in Patients with Multiple Sclerosis with and Without Pain as Sign of Central Sensitization.
Defining functional changes in the brain caused by targeted stereotaxic radiosurgery.
Processes of plasma protein N-homocysteinylation in multiple sclerosis.
The Y chromosome as a regulatory element shaping immune cell transcriptomes and susceptibility to autoimmune disease.
Ultrasonographic nerve enlargement of the median and ulnar nerves and the cervical nerve roots in patients with demyelinating Charcot-Marie-Tooth disease: distinction from patients with chronic inflammatory demyelinating polyneuropathy.
Severe Disability in Patients with Relapsing-Remitting Multiple Sclerosis Is Associated with Profound Changes in the Regulation of Leptin Secretion.
Epitopes of microbial and human heat shock protein 60 and their recognition in myalgic encephalomyelitis.
AQP4 autoantibody assay performance in clinical laboratory service.
The Scandinavian paradox revisited: Editorial comment on Berg-Hansen et al. 'High prevalence and no latitude gradient of multiple sclerosis in Norway'.
Uric acid in relapsing-remitting multiple sclerosis: a 2-year longitudinal study.
Evaluation of the effects of group psychotherapy on cognitive function in patients with multiple sclerosis with cognitive dysfunction and depression.
Neuroplasticity and motor rehabilitation in multiple sclerosis.
Simultaneous Determination of Oxysterols, Cholesterol and 25-Hydroxy-Vitamin D3 in Human Plasma by LC-UV-MS.
Pages
« first
‹ previous
…
556
557
558
559
560
561
562
563
564
…
next ›
last »